Blood biomarkers in cardioembolic stroke

Teresa García-Berrocoso; Israel Fernández-Cadenas; Pilar Delgado; Anna Rosell; Joan Montaner

doi:https://doi.org/10.2174/157340310791658767

Blood biomarkers in cardioembolic stroke

Teresa García-Berrocoso, Israel Fernández-Cadenas, Pilar Delgado, Anna Rosell, Joan Montaner

Research output: Contribution to journal › Article › Research › peer-review

13 Citations (Scopus)

Abstract

One promising field in neurovascular diseases investigation is the use of biomarkers to guide stroke etiology diagnosis and classification. Since treatment differs among etiologic subtypes and nowadays many patients receive a diagnosis of undetermined stroke, biomarkers might become an important additional diagnostic tool. In this review we update current knowledge about biomarkers related with cardioembolic stroke etiology (such as BNP and D-dimer proteins, or PITX2 and ZFHX3 genes), that in the future, might allow rapidly guiding other diagnostic tests and accelerating the onset of an optimal secondary prevention. © 2010 Bentham Science Publishers Ltd.

Original language	English
Pages (from-to)	194-201
Journal	Current Cardiology Reviews
Volume	6
Issue number	3
DOIs	https://doi.org/10.2174/157340310791658767
Publication status	Published - 17 Sep 2010

Keywords

Biomarker
Cardioembolic
Classification
Etiology
Natriuretic peptides
Stroke

Access to Document

https://doi.org/10.2174/157340310791658767

https://ddd.uab.cat/record/184757

Cite this

@article{94a36c426fee4ccaa44705eebf2f9029,

title = "Blood biomarkers in cardioembolic stroke",

abstract = "One promising field in neurovascular diseases investigation is the use of biomarkers to guide stroke etiology diagnosis and classification. Since treatment differs among etiologic subtypes and nowadays many patients receive a diagnosis of undetermined stroke, biomarkers might become an important additional diagnostic tool. In this review we update current knowledge about biomarkers related with cardioembolic stroke etiology (such as BNP and D-dimer proteins, or PITX2 and ZFHX3 genes), that in the future, might allow rapidly guiding other diagnostic tests and accelerating the onset of an optimal secondary prevention. {\textcopyright} 2010 Bentham Science Publishers Ltd.",

keywords = "Biomarker, Cardioembolic, Classification, Etiology, Natriuretic peptides, Stroke",

author = "Teresa Garc{\'i}a-Berrocoso and Israel Fern{\'a}ndez-Cadenas and Pilar Delgado and Anna Rosell and Joan Montaner",

year = "2010",

month = sep,

day = "17",

doi = "https://doi.org/10.2174/157340310791658767",

language = "English",

volume = "6",

pages = "194--201",

journal = "Current Cardiology Reviews",

issn = "1573-403X",

publisher = "Bentham Science Publishers B.V.",

number = "3",

}

TY - JOUR

T1 - Blood biomarkers in cardioembolic stroke

AU - García-Berrocoso, Teresa

AU - Fernández-Cadenas, Israel

AU - Delgado, Pilar

AU - Rosell, Anna

AU - Montaner, Joan

PY - 2010/9/17

Y1 - 2010/9/17

N2 - One promising field in neurovascular diseases investigation is the use of biomarkers to guide stroke etiology diagnosis and classification. Since treatment differs among etiologic subtypes and nowadays many patients receive a diagnosis of undetermined stroke, biomarkers might become an important additional diagnostic tool. In this review we update current knowledge about biomarkers related with cardioembolic stroke etiology (such as BNP and D-dimer proteins, or PITX2 and ZFHX3 genes), that in the future, might allow rapidly guiding other diagnostic tests and accelerating the onset of an optimal secondary prevention. © 2010 Bentham Science Publishers Ltd.

AB - One promising field in neurovascular diseases investigation is the use of biomarkers to guide stroke etiology diagnosis and classification. Since treatment differs among etiologic subtypes and nowadays many patients receive a diagnosis of undetermined stroke, biomarkers might become an important additional diagnostic tool. In this review we update current knowledge about biomarkers related with cardioembolic stroke etiology (such as BNP and D-dimer proteins, or PITX2 and ZFHX3 genes), that in the future, might allow rapidly guiding other diagnostic tests and accelerating the onset of an optimal secondary prevention. © 2010 Bentham Science Publishers Ltd.

KW - Biomarker

KW - Cardioembolic

KW - Classification

KW - Etiology

KW - Natriuretic peptides

KW - Stroke

U2 - https://doi.org/10.2174/157340310791658767

DO - https://doi.org/10.2174/157340310791658767

M3 - Article

VL - 6

SP - 194

EP - 201

JO - Current Cardiology Reviews

JF - Current Cardiology Reviews

SN - 1573-403X

IS - 3

ER -

Blood biomarkers in cardioembolic stroke

Abstract

Keywords

Access to Document

Fingerprint

Cite this